Towards improved hepatocyte cultures: Progress and limitations. 2020

Marc Ruoß, and Massoud Vosough, and Alfred Königsrainer, and Silvio Nadalin, and Silvia Wagner, and Sahar Sajadian, and Diana Huber, and Zahra Heydari, and Sabrina Ehnert, and Jan G Hengstler, and Andreas K Nussler
Department of Traumatology, Siegfried Weller Institute, Eberhard Karls University Tübingen, Tübingen, Germany.

Hepatotoxicity is among the most frequent reasons for drug withdrawal from the market. Therefore, there is an urgent need for reliable predictive in vitro tests, which unfailingly identify hepatotoxic drug candidates, reduce drug development time, expenses and the number of test animals. Currently, human hepatocytes represent the gold standard. However, the use of hepatocytes is challenging since the cells are not constantly available and lose their metabolic activity in culture. To solve these problems many different approaches have been developed in the past decades. The aim of this review is to present these approaches and to discuss the possibilities and limitations as well as future opportunities and directions.

UI MeSH Term Description Entries
D002460 Cell Line Established cell cultures that have the potential to propagate indefinitely. Cell Lines,Line, Cell,Lines, Cell
D002470 Cell Survival The span of viability of a cell characterized by the capacity to perform certain functions such as metabolism, growth, reproduction, some form of responsiveness, and adaptability. Cell Viability,Cell Viabilities,Survival, Cell,Viabilities, Cell,Viability, Cell
D003470 Culture Media Any liquid or solid preparation made specifically for the growth, storage, or transport of microorganisms or other types of cells. The variety of media that exist allow for the culturing of specific microorganisms and cell types, such as differential media, selective media, test media, and defined media. Solid media consist of liquid media that have been solidified with an agent such as AGAR or GELATIN. Media, Culture
D006801 Humans Members of the species Homo sapiens. Homo sapiens,Man (Taxonomy),Human,Man, Modern,Modern Man
D000076722 Drug Development The entire process of bringing a new drug to the market. It includes both preclinical and clinical testing, and regulatory approval. Computational Prediction of Drug-Target Interactions,Drug Target Prediction,Medication Development,Pharmaceutical Development,Development, Drug,Development, Medication,Development, Pharmaceutical,Drug Target Predictions,Prediction, Drug Target,Target Prediction, Drug
D017114 Liver Failure, Acute A form of rapid-onset LIVER FAILURE, also known as fulminant hepatic failure, caused by severe liver injury or massive loss of HEPATOCYTES. It is characterized by sudden development of liver dysfunction and JAUNDICE. Acute liver failure may progress to exhibit cerebral dysfunction even HEPATIC COMA depending on the etiology that includes hepatic ISCHEMIA, drug toxicity, malignant infiltration, and viral hepatitis such as post-transfusion HEPATITIS B and HEPATITIS C. Acute Hepatic Failure,Fulminant Hepatic Failure,Fulminating Hepatic Failure,Hepatic Failure, Fulminant,Liver Failure, Fulminant,Acute Liver Failure,Fulminating Liver Failure,Hepatic Failure, Acute,Failure, Acute Hepatic,Failure, Acute Liver,Fulminant Hepatic Failures,Fulminant Liver Failure,Fulminant Liver Failures,Fulminating Hepatic Failures,Fulminating Liver Failures,Hepatic Failure, Fulminating,Liver Failure, Fulminating
D049109 Cell Proliferation All of the processes involved in increasing CELL NUMBER including CELL DIVISION. Cell Growth in Number,Cellular Proliferation,Cell Multiplication,Cell Number Growth,Growth, Cell Number,Multiplication, Cell,Number Growth, Cell,Proliferation, Cell,Proliferation, Cellular
D054457 Tissue Scaffolds Cell growth support structures composed of BIOCOMPATIBLE MATERIALS. They are specially designed solid support matrices for cell attachment in TISSUE ENGINEERING and GUIDED TISSUE REGENERATION uses. Tissue Scaffolding,Scaffold, Tissue,Scaffolding, Tissue,Scaffoldings, Tissue,Scaffolds, Tissue,Tissue Scaffold,Tissue Scaffoldings
D056486 Chemical and Drug Induced Liver Injury A spectrum of clinical liver diseases ranging from mild biochemical abnormalities to ACUTE LIVER FAILURE, caused by drugs, drug metabolites, herbal and dietary supplements and chemicals from the environment. Drug-Induced Liver Injury,Liver Injury, Drug-Induced,Acute Liver Injury, Drug-Induced,Chemically-Induced Liver Toxicity,Drug-Induced Acute Liver Injury,Drug-Induced Liver Disease,Hepatitis, Drug-Induced,Hepatitis, Toxic,Liver Injury, Drug-Induced, Acute,Toxic Hepatitis,Acute Liver Injury, Drug Induced,Chemically Induced Liver Toxicity,Chemically-Induced Liver Toxicities,Disease, Drug-Induced Liver,Diseases, Drug-Induced Liver,Drug Induced Acute Liver Injury,Drug Induced Liver Disease,Drug Induced Liver Injury,Drug-Induced Hepatitides,Drug-Induced Hepatitis,Drug-Induced Liver Diseases,Drug-Induced Liver Injuries,Hepatitides, Drug-Induced,Hepatitides, Toxic,Hepatitis, Drug Induced,Injuries, Drug-Induced Liver,Injury, Drug-Induced Liver,Liver Disease, Drug-Induced,Liver Diseases, Drug-Induced,Liver Injuries, Drug-Induced,Liver Injury, Drug Induced,Liver Toxicities, Chemically-Induced,Liver Toxicity, Chemically-Induced,Toxic Hepatitides,Toxicities, Chemically-Induced Liver,Toxicity, Chemically-Induced Liver
D018874 Spheroids, Cellular Spherical, heterogeneous aggregates of proliferating, quiescent, and necrotic cells in culture that retain three-dimensional architecture and tissue-specific functions. The ability to form spheroids is a characteristic trait of CULTURED TUMOR CELLS derived from solid TUMORS. Cells from normal tissues can also form spheroids. They represent an in-vitro model for studies of the biology of both normal and malignant cells. (From Bjerkvig, Spheroid Culture in Cancer Research, 1992, p4) Multicellular Spheroids,Cellular Spheroid,Cellular Spheroids,Multicellular Spheroid,Spheroid, Cellular,Spheroid, Multicellular,Spheroids, Multicellular

Related Publications

Marc Ruoß, and Massoud Vosough, and Alfred Königsrainer, and Silvio Nadalin, and Silvia Wagner, and Sahar Sajadian, and Diana Huber, and Zahra Heydari, and Sabrina Ehnert, and Jan G Hengstler, and Andreas K Nussler
January 2014, The Journal of infection,
Marc Ruoß, and Massoud Vosough, and Alfred Königsrainer, and Silvio Nadalin, and Silvia Wagner, and Sahar Sajadian, and Diana Huber, and Zahra Heydari, and Sabrina Ehnert, and Jan G Hengstler, and Andreas K Nussler
March 2006, Lancet (London, England),
Marc Ruoß, and Massoud Vosough, and Alfred Königsrainer, and Silvio Nadalin, and Silvia Wagner, and Sahar Sajadian, and Diana Huber, and Zahra Heydari, and Sabrina Ehnert, and Jan G Hengstler, and Andreas K Nussler
October 2020, Joint bone spine,
Marc Ruoß, and Massoud Vosough, and Alfred Königsrainer, and Silvio Nadalin, and Silvia Wagner, and Sahar Sajadian, and Diana Huber, and Zahra Heydari, and Sabrina Ehnert, and Jan G Hengstler, and Andreas K Nussler
January 1986, Progress in liver diseases,
Marc Ruoß, and Massoud Vosough, and Alfred Königsrainer, and Silvio Nadalin, and Silvia Wagner, and Sahar Sajadian, and Diana Huber, and Zahra Heydari, and Sabrina Ehnert, and Jan G Hengstler, and Andreas K Nussler
October 1998, BioDrugs : clinical immunotherapeutics, biopharmaceuticals and gene therapy,
Marc Ruoß, and Massoud Vosough, and Alfred Königsrainer, and Silvio Nadalin, and Silvia Wagner, and Sahar Sajadian, and Diana Huber, and Zahra Heydari, and Sabrina Ehnert, and Jan G Hengstler, and Andreas K Nussler
February 2014, Cirugia espanola,
Marc Ruoß, and Massoud Vosough, and Alfred Königsrainer, and Silvio Nadalin, and Silvia Wagner, and Sahar Sajadian, and Diana Huber, and Zahra Heydari, and Sabrina Ehnert, and Jan G Hengstler, and Andreas K Nussler
June 1999, Chemico-biological interactions,
Marc Ruoß, and Massoud Vosough, and Alfred Königsrainer, and Silvio Nadalin, and Silvia Wagner, and Sahar Sajadian, and Diana Huber, and Zahra Heydari, and Sabrina Ehnert, and Jan G Hengstler, and Andreas K Nussler
May 2007, Veterinary journal (London, England : 1997),
Marc Ruoß, and Massoud Vosough, and Alfred Königsrainer, and Silvio Nadalin, and Silvia Wagner, and Sahar Sajadian, and Diana Huber, and Zahra Heydari, and Sabrina Ehnert, and Jan G Hengstler, and Andreas K Nussler
January 2006, Methods in molecular biology (Clifton, N.J.),
Marc Ruoß, and Massoud Vosough, and Alfred Königsrainer, and Silvio Nadalin, and Silvia Wagner, and Sahar Sajadian, and Diana Huber, and Zahra Heydari, and Sabrina Ehnert, and Jan G Hengstler, and Andreas K Nussler
January 2006, Methods in molecular biology (Clifton, N.J.),
Copied contents to your clipboard!